Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Hollenberg, Steven M ^a   Piotrowski, Mark J ^a   Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

N(G) monomethyl L arginine; sepsis; vasopressor responsiveness; videomicroscopy

Indexed keywords

ENDOTHELIN 1; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

EID: 0031004322     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.272.3.r969     Document Type: Article

References (35)

1. Alexander, H. R., B. C. Sheppard, J. C. Jensen, H. N. Langstein, C. M. Buresh, D. Venzon, E. C. Walker, D. L. Fraker, M. C. Stovroff, and J. A. Norton. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J. Clin. Invest. 88: 34-39, 1991.
2. Baez, S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc. Res. 5: 384-394, 1973.
3. Baudry, N., E. Vicaut, and Z. F. Ba. Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in rat. J. Appl. Physiol. 75: 2392-2399, 1993.
4. Beasley, D., R. A. Cohen, and N. G. Levinsky. Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1187-H1192, 1990.
5. Bohlen, H. G., R. W. Gore, and P. M. Hutchins. Comparison of microvascular pressures in normal and spontaneously hypertensive rats. Microvasc. Res. 13: 125-130, 1977.
6. Chernow, B., T. R. Rainey, and C. R. Lake. Endogenous and exogenous catecholamines in critical care medicine. Crit. Care Med. 10: 409-416, 1982.
7. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176: 1175-1182, 1992.
8. Cunnion, R. E., and J. E. Parrillo. Myocardial dysfunction in sepsis. Recent insights. Chest 95: 941-945, 1989.
9. Fleming, I., G. Julou-Schaeffer, G. A. Gray, J. R. Parratt, and J.-C. Stoclet. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br. J. Pharmacol. 103: 1047-1052, 1991.
10. Fronek, K., and B. W. Zweifach. Microvascular pressure distribution in skeletal muscle and the effect of vasodilation. Am. J. Physiol. 228: 791-796, 1975.
11. Gray, G., C. Schott, G. Julou-Schaeffer, I. Fleming, J. R. Parratt, and J.-C. Stoclet. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br. J. Pharmacol. 103: 1218-1244, 1991.
12. Harbrecht, B. G., T. R. Billiar, J. Stadler, A. J. Demetris, J. Ochoa, R. D. Curran, and R. L. Simmons. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukocyte Biol. 52: 390-394, 1992.
13. Hollenberg, S. M., and R. E. Cunnion. Endothelial and vascular smooth muscle function in sepsis. J. Crit. Care 9: 262-280, 1994.
14. Hollenberg, S. M., R. E. Cunnion, and J. E. Parrillo. The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. Chest 100: 1133-1137, 1991.
15. Hollenberg, S. M., R. E. Cunnion, and J. Zimmerberg. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H660-H663, 1993.
16. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J.-C. Stoclet. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1038-H1043, 1990.
17. Kiowski, W., T. F. Luscher, L. Linder, and F. R. Buhler. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83: 469-475, 1991.
18. Lorente, J. A., L. Landin, R. De Pablo, E. Renes, and D. Liste. L-Arginine pathway in the sepsis syndrome. Crit. Care Med. 21: 1287-1295, 1993.
19. Luscher, T. F. The endothelium as a target and mediator of cardiovascular disease. Eur. J. Clin. Invest. 23: 670-685, 1993.
20. Marshall, J. J., and H.A. Kontos. Endothelium-derived relaxing factors. A perspective from in vivo data. Hypertension 16: 371-386, 1990.
21. McKenna, T. M. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. J. Clin. Invest. 86: 160-168, 1990.
22. McKenna, T. M., F. M. Martin, B. Chernow, and F. A. Briglia. Vascular endothelium contributes to decreased aortic contractility in experimental sepsis. Circ. Shock 19: 267-273, 1986.
23. Messina, E. J., J. Rodenburg, and G. Kaley. Microcirculatory effects of leukotrienes, LTC 4 and LTD 4, in rat cremaster muscle. Microcirc. Endothelium Lymphatics 5: 355-375, 1988.
24. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064, 1992.
25. Paya, D., G. A. Gray, I. Fleming, and J.-C. Stoclet. Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ. Shock 41: 103-112, 1993.
26. Petros, A., G. Lamb, A. Leone, S. Moncada, D. Bennett, and P. Vallance. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39, 1995.
27. Salvemini, D., T. P. Misko, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90: 7240-7244, 1993.
28. Thiemermann, C., and J. Vane. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182: 591-595, 1990.
29. Thiemermann, C., C.-C. Wu, C. Szabo, M. Perretti, and J. R. Vane. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110: 177-182, 1993.
30. Vicaut, E., X. Hou, D. Payen, A. Bousseau, and A. Tedgui. Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. J. Clin. Invest. 87: 1537-1540, 1991.
31. Weitzberg, E., J. M. Lundberg, and A. Rudehill. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ. Shock 33: 222-227, 1991.
32. Wiedeman, M. P. Architecture of the terminal vascular bed. In: Physical Bases of Circulatory Transport: Regulation and Exchange, edited by E. B. Reeve and A. C. Guyton. Philadelphia, PA: Saunders, 1976, p. 307-312.
33. Wu, C.-C., C. Szabo, S.-J. Chen, C. Thiemermann, and J. R. Vane. Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta or rats treated with endotoxin. Biochem. Biophys. Res. Commun. 201: 436-442, 1994.
34. Yanagisawa, M. The endothelin system. A new target for therapeutic intervention. Circulation 89: 1320-1322, 1994.
35. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.